CN114938835A - 一种二氢槲皮素sod胶原三肽饮配方 - Google Patents
一种二氢槲皮素sod胶原三肽饮配方 Download PDFInfo
- Publication number
- CN114938835A CN114938835A CN202210716964.0A CN202210716964A CN114938835A CN 114938835 A CN114938835 A CN 114938835A CN 202210716964 A CN202210716964 A CN 202210716964A CN 114938835 A CN114938835 A CN 114938835A
- Authority
- CN
- China
- Prior art keywords
- sod
- dihydroquercetin
- vitamin
- collagen
- collagen tripeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 82
- 108010035532 Collagen Proteins 0.000 title claims abstract description 82
- 229920001436 collagen Polymers 0.000 title claims abstract description 81
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 title claims abstract description 42
- XCGZWJIXHMSSQC-UHFFFAOYSA-N dihydroquercetin Natural products OC1=CC2OC(=C(O)C(=O)C2C(O)=C1)c1ccc(O)c(O)c1 XCGZWJIXHMSSQC-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 102000019197 Superoxide Dismutase Human genes 0.000 title 2
- 108010012715 Superoxide dismutase Proteins 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 24
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 24
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 24
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 20
- 239000000811 xylitol Substances 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 20
- 229960002675 xylitol Drugs 0.000 claims abstract description 20
- 102000016942 Elastin Human genes 0.000 claims abstract description 19
- 108010014258 Elastin Proteins 0.000 claims abstract description 19
- 229920002549 elastin Polymers 0.000 claims abstract description 19
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 18
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 18
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 18
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 17
- 229940124277 aminobutyric acid Drugs 0.000 claims abstract description 16
- 244000000626 Daucus carota Species 0.000 claims abstract description 15
- 235000005770 birds nest Nutrition 0.000 claims abstract description 15
- 235000005765 wild carrot Nutrition 0.000 claims abstract description 15
- 241000269851 Sarda sarda Species 0.000 claims abstract description 14
- 239000008213 purified water Substances 0.000 claims abstract description 14
- 239000012141 concentrate Substances 0.000 claims abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 60
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 47
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 29
- 229930003427 Vitamin E Natural products 0.000 claims description 23
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 23
- 235000019165 vitamin E Nutrition 0.000 claims description 23
- 239000011709 vitamin E Substances 0.000 claims description 23
- 229940046009 vitamin E Drugs 0.000 claims description 23
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 18
- 239000004302 potassium sorbate Substances 0.000 claims description 18
- 229940069338 potassium sorbate Drugs 0.000 claims description 18
- 235000010241 potassium sorbate Nutrition 0.000 claims description 18
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 16
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 16
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 16
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 16
- 239000004376 Sucralose Substances 0.000 claims description 15
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 15
- 229940116298 l- malic acid Drugs 0.000 claims description 15
- 235000011090 malic acid Nutrition 0.000 claims description 15
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 15
- 235000019408 sucralose Nutrition 0.000 claims description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 8
- 229940088594 vitamin Drugs 0.000 abstract description 8
- 229930003231 vitamin Natural products 0.000 abstract description 8
- 235000013343 vitamin Nutrition 0.000 abstract description 8
- 239000011782 vitamin Substances 0.000 abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 7
- 230000002087 whitening effect Effects 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 229960003966 nicotinamide Drugs 0.000 abstract description 4
- 235000005152 nicotinamide Nutrition 0.000 abstract description 4
- 239000011570 nicotinamide Substances 0.000 abstract description 4
- 229920002567 Chondroitin Polymers 0.000 abstract description 3
- 230000003796 beauty Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 56
- 230000000694 effects Effects 0.000 description 43
- 235000013305 food Nutrition 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000002994 raw material Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 230000003405 preventing effect Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004927 skin cell Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241000962514 Alosa chrysochloris Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000011265 semifinished product Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000005562 fading Methods 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000028990 Skin injury Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000004920 epithelial cell of skin Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000004833 fish glue Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000009609 fructus phyllanthi Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- -1 oxygen free radical Chemical class 0.000 description 2
- 235000013944 peach juice Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
- 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010051131 Mastoptosis Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040639 Sick sinus syndrome Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000032724 odontogenesis Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明涉及饮料技术领域,具体涉及一种二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:纯化水60‑80%、水蜜桃浓缩5‑25%、木糖醇1‑10%,透明质酸钠0.1‑0.5%、胶原三肽1‑6%、鲣鱼弹性蛋白肽0.5‑3.5%、鳕鱼胶原蛋白肽0.5‑3.5%、余甘子0.1‑2.5%、雨生红球藻0.1‑0.8%、氨基丁酸0.1‑0.5%、燕窝0.1‑0.5%、含Sod酵母粉0.05‑0.15%、二氢槲皮素0.01‑0.05%、维生素C0.01‑0.05%、维生素E0.01‑0.05%、烟酰胺0.005‑0.015%;它具有美容养颜抗衰老、补水、锁水、清除自由基,以及能够改善睡眠、美白淡斑、修复软骨素等优点。
Description
技术领域
本发明涉及饮料技术领域,具体涉及一种二氢槲皮素SOD胶原三肽饮配方。
背景技术
随着人们生活水平提高,人们喜欢喝各种不同风味的饮料。传统的饮料是经过定量包装的,供直接饮用或按一定比例用水冲调或冲泡饮用的,乙醇含量不超过0.5%的制品,其作用是解渴、补充能量等功能。但是上述的饮料的功能单一,不具有养颜抗衰老补水、锁水功能,以及也不具备改善睡眠、美白淡斑等功能,因此本设计是将饮料与人们所喜爱的美容以及身体微健康相结合,形成与传统饮料不同的饮品。
发明内容
本发明的目的在于针对现有技术的缺陷和不足,提供一种二氢槲皮素SOD胶原三肽饮配方。
本发明所述的一种二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水60-80%、水蜜桃浓缩5-25%、木糖醇1-10%,
透明质酸钠0.1-0.5%、胶原三肽1-6%、鲣鱼弹性蛋白肽0.5-3.5%、鳕鱼胶原蛋白肽0.5-3.5%、余甘子0.1-2.5%、雨生红球藻0.1-0.8%、氨基丁酸0.1-0.5%、燕窝0.1-0.5%、含Sod酵母粉0.05-0.15%、二氢槲皮素0.01-0.05%、
维生素C0.01-0.05%、维生素E0.01-0.05%、烟酰胺0.005-0.015%、羧甲基纤维素钠0.005-0.015%、柠檬酸0.005-0.015%、L-苹果酸0.005-0.015%、三氯蔗糖0.001-0.009%、山梨酸钾0.001-0.009%、食用香精0.0005-0.005%。
进一步地,二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水71.389%、水蜜桃浓缩15%、木糖醇5%、透明质酸钠0.2%、胶原三肽3%、鲣鱼弹性蛋白肽2%、鳕鱼胶原蛋白肽2%、余甘子0.5%、雨生红球藻0.3%、氨基丁酸0.2%、燕窝0.2%、含Sod酵母粉0.1%、二氢槲皮素0.02%、维生素C0.02%、维生素E0.02%、烟酰胺0.01%、羧甲基纤维素钠0.01%、柠檬酸0.01%、L-苹果酸0.01%、三氯蔗糖0.005%、山梨酸钾0.004%、食用香精0.002%。
进一步地,二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水70.592%、水蜜桃浓缩13.5%、木糖醇4.5%、透明质酸钠0.15%、胶原三肽4%、鲣鱼弹性蛋白肽3%、鳕鱼胶原蛋白肽3%、余甘子0.4%、雨生红球藻0.2%、氨基丁酸0.25%、燕窝0.25%、含Sod酵母粉0.15%、二氢槲皮素0.025%、维生素C0.025%、维生素E0.025%、烟酰胺0.015%、羧甲基纤维素钠0.015%、柠檬酸0.015%、L-苹果酸0.015%、三氯蔗糖0.004%、山梨酸钾0.003%、食用香精0.001%。
进一步地,二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水68.978%、水蜜桃浓缩12.5%、木糖醇4.%、透明质酸钠0.1%、胶原三肽5%、鲣鱼弹性蛋白肽4%、鳕鱼胶原蛋白肽4%、余甘子0.45%、雨生红球藻0.25%、氨基丁酸0.255%、燕窝0.255%、含Sod酵母粉0.155%、二氢槲皮素0.0255%、维生素C0.0255%、维生素E0.0255%、烟酰胺0.0155%、羧甲基纤维素钠0.0155%、柠檬酸0.0155%、L-苹果酸0.0155%、三氯蔗糖0.0045%、山梨酸钾0.0035%、食用香精0.0005%。
二氢槲皮素SOD胶原三肽饮的制备工艺,采用如下步骤:
步骤一:将水蜜桃浓缩5-25%、木糖醇1-10%、透明质酸钠0.1-0.5%、胶原三肽1-6%、鲣鱼弹性蛋白肽0.5-3.5%、鳕鱼胶原蛋白肽0.5-3.5%、余甘子0.1-2.5%、雨生红球藻0.1-0.8%、氨基丁酸0.1-0.5%、燕窝0.1-0.5%、含Sod酵母粉0.05-0.15%、二氢槲皮素0.01-0.05%、维生素C0.01-0.05%、维生素E0.01-0.05%、烟酰胺0.005-0.015%、羧甲基纤维素钠0.005-0.015%、柠檬酸0.005-0.015%、L-苹果酸0.005-0.015%、三氯蔗糖0.001-0.009%、山梨酸钾0.001-0.009%、食用香精0.0005-0.005%,加入纯化水60-80%,进行回流提取,形成原料提取液;
步骤二:将步骤一中的原料提取液,进行絮凝沉淀,形成上清液原料;
步骤三:将步骤二中的上清液原料,经过滤器过滤,离心泵离心,实现分离,形成半成品液;
步骤四:将步骤三中的半成品液,再进行浓缩、灭菌,形成产成品原液;
步骤五:将步骤四中的产成品原液,真空灌装,形成二氢槲皮素SOD胶原三肽饮罐成品。
本发明的制备工艺,采用对原料进行提取、回流,然后过滤、离心,实现分离,再进行浓缩、灭菌、灌装,从而实现产品化。
本发明有益效果为:本发明所述的一种二氢槲皮素SOD胶原三肽饮配方,它具有美容养颜抗衰老、补水、锁水、清除自由基,以及能够改善睡眠、美白淡斑、修复软骨素等优点。
具体实施方式
下面以具体实施例来详细说明本发明,其中的示意性实施例以及说明仅用来解释本发明,但并不作为对本发明的限定。
本具体实施方式所述的一种二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水60-80%、水蜜桃浓缩5-25%、木糖醇1-10%,
透明质酸钠0.1-0.5%、胶原三肽1-6%、鲣鱼弹性蛋白肽0.5-3.5%、鳕鱼胶原蛋白肽0.5-3.5%、余甘子0.1-2.5%、雨生红球藻0.1-0.8%、氨基丁酸0.1-0.5%、燕窝0.1-0.5%、含Sod酵母粉0.05-0.15%、二氢槲皮素0.01-0.05%、
维生素C0.01-0.05%、维生素E0.01-0.05%、烟酰胺0.005-0.015%、羧甲基纤维素钠0.005-0.015%、柠檬酸0.005-0.015%、L-苹果酸0.005-0.015%、三氯蔗糖0.001-0.009%、山梨酸钾0.001-0.009%、食用香精0.0005-0.005%。
具体实施例一:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水71.389%、水蜜桃浓缩15%、木糖醇5%、透明质酸钠0.2%、胶原三肽3%、鲣鱼弹性蛋白肽2%、鳕鱼胶原蛋白肽2%、余甘子0.5%、雨生红球藻0.3%、氨基丁酸0.2%、燕窝0.2%、含Sod酵母粉0.1%、二氢槲皮素0.02%、维生素C0.02%、维生素E0.02%、烟酰胺0.01%、羧甲基纤维素钠0.01%、柠檬酸0.01%、L-苹果酸0.01%、三氯蔗糖0.005%、山梨酸钾0.004%、食用香精0.002%。
具体实施例二:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水70.592%、水蜜桃浓缩13.5%、木糖醇4.5%、透明质酸钠0.15%、胶原三肽4%、鲣鱼弹性蛋白肽3%、鳕鱼胶原蛋白肽3%、余甘子0.4%、雨生红球藻0.2%、氨基丁酸0.25%、燕窝0.25%、含Sod酵母粉0.15%、二氢槲皮素0.025%、维生素C0.025%、维生素E0.025%、烟酰胺0.015%、羧甲基纤维素钠0.015%、柠檬酸0.015%、L-苹果酸0.015%、三氯蔗糖0.004%、山梨酸钾0.003%、食用香精0.001%。
具体实施例三:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水68.978%、水蜜桃浓缩12.5%、木糖醇4.%、透明质酸钠0.1%、胶原三肽5%、鲣鱼弹性蛋白肽4%、鳕鱼胶原蛋白肽4%、余甘子0.45%、雨生红球藻0.25%、氨基丁酸0.255%、燕窝0.255%、含Sod酵母粉0.155%、二氢槲皮素0.0255%、维生素C0.0255%、维生素E0.0255%、烟酰胺0.0155%、羧甲基纤维素钠0.0155%、柠檬酸0.0155%、L-苹果酸0.0155%、三氯蔗糖0.0045%、山梨酸钾0.0035%、食用香精0.0005%。
本发明中,二氢槲皮素SOD胶原三肽饮的制备工艺,采用如下步骤:
步骤一:将水蜜桃浓缩5-25%、木糖醇1-10%、透明质酸钠0.1-0.5%、胶原三肽1-6%、鲣鱼弹性蛋白肽0.5-3.5%、鳕鱼胶原蛋白肽0.5-3.5%、余甘子0.1-2.5%、雨生红球藻0.1-0.8%、氨基丁酸0.1-0.5%、燕窝0.1-0.5%、含Sod酵母粉0.05-0.15%、二氢槲皮素0.01-0.05%、维生素C0.01-0.05%、维生素E0.01-0.05%、烟酰胺0.005-0.015%、羧甲基纤维素钠0.005-0.015%、柠檬酸0.005-0.015%、L-苹果酸0.005-0.015%、三氯蔗糖0.001-0.009%、山梨酸钾0.001-0.009%、食用香精0.0005-0.005%,加入纯化水60-80%,进行回流提取,形成原料提取液;
步骤二:将步骤一中的原料提取液,进行絮凝沉淀,形成上清液原料;
步骤三:将步骤二中的上清液原料,经过滤器过滤,离心泵离心,实现分离,形成半成品液;
步骤四:将步骤三中的半成品液,再进行浓缩、灭菌,形成产成品原液;
步骤五:将步骤四中的产成品原液,真空灌装,形成二氢槲皮素SOD胶原三肽饮罐成品。
本发明的制备工艺,采用对原料进行提取、回流,然后过滤、离心,实现分离,再进行浓缩、灭菌、灌装,从而实现产品化。
本发明采用如下制备工艺:液体的工艺:提取、回流、过滤、离心、浓缩、灭菌、灌装。
本发明中各组成成份的功效和作用,陈述如下:
1、纯化水是蒸馏法、离子交换法、反渗透法或其他适宜的方法制得供药用的水,不含任何附加剂。性状:为无色的澄明液体;无臭,无味。
2、水蜜桃浓缩汁:桃汁有补益血、养阴生津的作用,桃汁可用于大病之后、气血亏虚、面黄肌瘦、心悸气短者桃。以及桃子的主要成份为蔗糖,而维生素与矿物质的含量较少,但是纤维成份的果胶颇多,桃汁有整肠的功用。
3、木糖醇是一种有机化合物,化学式是C5H12O5,原产于芬兰,是从白桦树、橡树、玉米芯、甘蔗渣等植物原料中提取出来的一种天然甜味剂。
木糖醇甜度与蔗糖相当,溶于水时可吸收大量热量,是所有糖醇甜味剂中吸热值最大的一种,故以固体形式食用时,会在口中产生愉快的清凉感。木糖醇不致龋且有防龋齿的作用。代谢不受胰岛素调节,在人体内代谢完全,热值为10kJ/g[1],可作为糖尿病人的热能源。
作为甜味剂使用。木糖醇也能透过细胞膜,被组织吸收利用,促进肝糖原合成,供细胞以营养和能量,且不会引起血糖值升高。可改善肝的作用。木糖醇能促进肝糖元合成,血糖不会上升,对肝病患者有改善肝功能和抗脂肪肝的作用,治疗乙型迁延性肝炎,乙型慢性肝炎及肝硬化有明显疗效。可防龋齿。利于减肥。
4、透明质酸钠:保湿作用、营养作用、皮肤损伤修复。透明质酸又叫做玻尿酸,是一种粘多糖,广泛地存在于人体组织中,透明质酸的钠盐形式叫做透明质酸钠,是一种功效性化妆品原料,现广泛应用于各类医用护肤品及洗护产品中。透明质酸有以下几个方面的作用:一、保湿作用,保湿作用是透明质酸钠在化妆品中最重要的作用,透明质酸的吸水能力非常强,是公认的天然保湿因子。二、营养作用,透明质酸钠是皮肤固有的物质,外源性的透明质酸钠是对皮肤内源性的补充,小分子的透明质酸钠可深入皮肤的表皮层,促进皮肤营养的供给以及废物的排泄,从而防止皮肤老化,起到一定的美容和养颜的作用。三、透明质酸钠有促进皮肤损伤修复的作用,可以通过促进表皮细胞的增殖和分化,加速表皮细胞的再生,从而促进损伤部位皮肤的愈合。四、透明质酸钠属于高分子的聚合物,它有很强的润滑感和成膜性。还有透明质酸钠的护肤品,涂抹于皮肤时会感觉很润滑,手感良好,涂于皮肤以后,还可以在皮肤表面形成一层薄膜,对皮肤有一定的保护作用。
5、胶原三肽:保湿:胶原三肽中含亲水性的天然保湿因子,而且稳定的三螺旋结构能强劲锁住水分,让皮肤时刻保持湿润、水嫩的状态!胶原蛋白与胶原肽均具有保湿的作用,由于CTP即含有分子量小的部分,又含有分子量大的部分,因此它不仅具有同样的护肤作用,且更为稳定和明显。应用阻抗仪测定电导度值来表征角质层的水分含量。结果表明,CTP的应用不仅保持住水分,而且是其水分含量增加,起到了保湿作用。
滋养:胶原三肽对皮肤的渗透性较胶原蛋白更强,它可透过角质层与皮肤上皮细胞结合,参与和改善皮肤细胞的代谢,使皮肤中的胶原蛋白活性加强,保持角质层水分及纤维结构的完整性,改善皮肤细胞生存环境和促进皮肤组织的新陈代谢,增强血液循环,达到滋润皮肤的目的。亮肤:皮肤的光泽取决于含水量,胶原三肽良好的保水能力使皮肤水润亮泽,散发健康的光彩。
紧肤:当胶原三肽被皮肤吸收后,填充在皮肤真皮之间,增加皮肤紧密度,产生皮肤张力,缩小毛孔,使皮肤紧绷而富有弹性!
防皱:真皮中含有丰满的胶原蛋白层,而补充胶原三肽,能更有效的将皮肤细胞撑起,结合保湿和抑制皱纹的作用,共同达到舒展粗纹,淡化细纹的功效!
修复:胶原三肽能直接渗入肌肤底层,且与周围组织的亲和性好,可协助细胞制造成胶原蛋白,促使皮肤细胞正常成长。
营养:胶原三肽对皮肤的渗透性强,可透过角质层与皮肤上皮细胞结合,参与和改善皮肤细胞的代谢,使皮肤中的胶原蛋白活性加强。它能保持角质层水分及纤维结构的完整性,改善皮肤细胞生存环境和促进皮肤组织的新陈代谢,增强血液循环,达到滋润皮肤的目的。胶原三肽中独有的羟脯氨酸具有收紧结缔组织的作用,能使松弛的组织紧实、承托起下垂的乳房,使乳房挺拔、丰满、富有弹性。
6、鲣鱼弹性蛋白肽:鲣鱼弹性蛋白肽的作用和功效是提高自身免疫力,皮肤的柔软性以及弹性通常和弹性蛋白有很大关系。如果因为光线等因素,使皮肤出现了生理性老化的情况,用鲣鱼弹性蛋白肽能起到抗衰老的作用,还能加速细胞再生,有美容养颜的效果。平时还要多吃鱼皮或者是猪蹄等胶原蛋白含量高的食物。
是滋养细胞、补水美白。通过这种材料,细胞既能增加胶原蛋白的营养,又能促进人体血液循环。使血液中的沉淀物排出体外,从而紧致肌肤,收缩毛孔。鱼胶原肽粉能修复断裂和老化的纤维,重组皮肤结构。还能使身体结构得到拉伸,具有延缓衰老的作用,并能阻止皱纹的产生。
7、鳕鱼胶原蛋白肽:鱼胶蛋白肽的作用是能够滋养肌肤、防止肌肤长出皱纹,还能够加强皮肤中的胶原蛋白活性,增强血液循环,使毛孔缩小、细纹淡化,有效防止皮肤老化。鱼胶蛋白肽还能够滋养头皮,修复干枯毛燥的头发,具有能够缓解机体疲劳、增强机体免疫力的功效。想要改善皮肤,建议可以去正规的医院注射胶原蛋白,滋养皮肤的效果比较好。
8、余甘子是一味中药,功效是清热凉血,消食健胃,生津止咳。作用主要在于肺脏和胃两个脏器,通常可用来治疗血热、血瘀、消化不良、腹胀、腹痛、口干、咽喉疼痛、咳嗽。余甘子具有一定的寒凉的性质,所以很多脾胃虚寒的人、身体弱的人,应该谨慎服用。余甘子的果实可以做食物,也可以做成甜点,可以增强人体的免疫力,是非常好的零食。在临床中,余甘子每次的用量不要太大,一般10克以内,主张入丸散剂。
9、雨生红球藻可以抗衰老。人体的衰老,主要是由于自由基所造成的氧化所至,而雨生红球藻中的天然虾青素,则可以穿越人体细胞外壁,直接清除细胞内的氧自由基,增强细胞再生能力,保护细胞和DNA健康,减少衰老细胞堆积,起到延缓衰老的功效。还有保护皮肤,预防皮肤炎和皮肤癌;坚固皮肤“保温屏障”,充分保持皮肤水分,从而起到抗皱、防晒、保湿、美白的功效。增强力量和耐力。减少肌肉损伤,缩短恢复时间;促进脂肪燃烧,获得更高能量等级;维持剧烈运动后的关节功能,预防肥胖。对人们有很好的功效,促进吸收,提高免疫力。
10、氨基丁酸:γ-氨基丁酸的作用和功效,主要有以下几个方面:
1、可抗焦虑、抗抑郁、缓解压力、调节情绪、缓解精神紧张、促使神经安定,γ-氨基丁酸能够组合与焦虑相关的信息,达到大脑的中枢,对人的自律神经具有调节作用,提高和发挥个人的表现力;
2具有改善睡眠、帮助促进睡眠的作用,足量的γ-氨基丁酸使人进入深度的睡眠状态,对容易胡思乱想、大脑停不下来的情况有调节作用,可使大脑冷静下来,是天然的大脑镇静剂;
3提高脑活力、促进脑血流、提高葡萄糖磷酸酯酶活性,增加乙酰胆碱生成,扩张血管增加血流量,增加氧供给,促进大脑的新陈代谢;
4其他:改善肝肾功能,另外具有解酒功效,可以降低血压。
11、燕窝是大家非常熟悉的高端食品,进入高档餐厅后可发现这种菜品非常昂贵,因其可以滋补养颜,帮助疾病康复。燕窝含有表皮生长因子和促进细胞分裂的激素,可以促进细胞生长及增殖。其中富含的生物活性蛋白分子,可以增加人体的免疫功能,同时含有的燕窝酸,长期服用可以增加体内氨基酸和胶原蛋白的合成,有一定的美容功效。另外,燕窝的蛋白质含量非常之高,通过查食物成分表,可以了解到干燕窝的蛋白质含量高达40%。其中还含有唾液酶,唾液酸是一种天然存在的碳水化合物,可以阻止病菌入侵,预防感冒。总之,燕窝具有保健和医疗的功效,滋阴润肺、补而不燥,而且养颜美容,使皮肤光滑有弹性;补中益气、促进血液循环,促进胃消化和肠道吸收力,治疗盗汗、咳血等症状,同时对胃气虚、胃阴虚所导致的反胃干呕等症状也有一定的缓解。
12、含Sod酵母粉:sod酵母粉通常具有改善身体营养不良和缺铁性贫血等功效。酵母粉中含有非常丰富的蛋白质,可以增进食欲。其作用是用于治疗消化不良、呕吐、多发性神经炎等症状。但不可以过量服用,否则会导致腹泻。
13、二氢槲皮素:具有止咳平喘、清热解毒的作用。槲皮素能起到止咳平喘、消肿利尿、清热解毒、提高免疫力的作用。适用于失眠健忘胸闷气短心慌多梦记忆力减退,腰膝酸软,四肢无力口干口苦,慢性支气管炎等症。具有降压、降血脂、降胆固醇、增强毛细血管抵抗力、减少毛细血管内垃圾及毒素。防止冠心病、冠心病、心绞痛、心肌缺血、心律失常。
14、维生素C:维生素c的作用和功效有很多。它可以促进铁、钙、叶酸的吸收利用,从而转化成人体所需要的营养素,帮助提高人体免疫。维生素c还可以促进骨质代谢和胶原纤维的生成,可以促进骨骼和牙齿的发育。维生素c还具有美白和防晒的功能。
15、维生素E:维生素E可以促进性激素的分泌,而提高女性的生育能力。维生素E还有抗氧化和抗自由基的作用,利用维生素E的抗氧化、抗自由基的作用,可以淡化面部的色斑。因此,维生素E的制剂作为护肤品,已经在皮肤科广泛应用。维生素E是一种脂溶性的维生素,其水解产物为生育酚,是最主要的抗氧化剂之一。
维生素E还有抗氧化、抗自由基的作用,维生素E的抗氧化和抗自由基的作用可以淡化色斑,面部的色素斑常常与脂褐素在皮肤的沉积有关,维生素E能够中和其自由基,而有利于色素性斑点的去除。维生素E有促进女性雌激素水平升高的作用,使皮肤更有弹性,延缓皮肤的衰老,减少皮肤的细纹。因此,长期外用维生素E作为护肤品,对滋润皮肤、淡化色斑、保护皮肤都有一定的临床效果。
16、烟酰胺:主要用于防治糙皮病、口炎、舌炎,病态窦房结综合征,房室传导阻滞等问题。
17、羧甲基纤维素钠:羧甲基纤维素钠也是增稠剂的一种,由于其本身具有良好的功能特性使其在食品工业得到了广泛的应用,它也在一定程度上推动了食品工业快速健康的发展。如由于其具有一定的增稠乳化作用,可以用于稳定酸乳饮料并可增加酸奶体系的黏稠性;由于其具有一定的亲水性和复水性,可以用于改进面包和馒头等面食的食用品质,延长面食制品的货架期、提升口感;由于其具有一定的凝胶作用,有利于食品更好地形成凝胶,因此能够用于制造果冻和果酱等;其也可以作为可食性的涂膜材料,与其他增稠剂复配使用,涂抹在一些食品表面,可最大程度地使食品保鲜,且由于是可食性材料,对人体健康不会造成不良影响。因此,食用级的CMC-Na作为一种理想的食品添加剂,在食品工业的食品生产中应用非常普遍。
18、柠檬酸:有明显的抑制细菌、杀菌、防腐作用。适量的柠檬酸还可以提高人的食欲、增强机体的代谢,它是一种重要的有机酸,又称之为枸橼酸。柠檬酸可以用于天然食品以及加工的食品之中。像柠檬它含有天然的柠檬酸,饮料、罐头、果酱和糖果中也含有一定量的柠檬酸。
19、L-苹果酸:用做加工和配置饮料、露酒、果汁,也用于糖果、果酱等的制造,对食品且有抑菌防腐作用。亦可用于酸乳发酵PH调节,葡萄酒酿造中除酒石酸盐等。可以配入氨基酸溶液中,能明显提高氨基酸的吸收率;L-苹果可以用于治疗肝病、贫血、免疫力低下、尿毒症、高血压、肝衰竭等多种疾病,并能减轻抗癌药物对正常细胞的毒害作用。
20、三氯蔗糖:是纯天然产物蔗糖的衍生物,对蔗糖的相对甜度随溶液浓度而变化,它对酸味和咸味有淡化效果,对涩味、苦味、酒味等味道有掩盖效果,对辛辣、奶味等有增效作用。
21、山梨酸钾:主要用于一些物品或者东西的防腐,如果食物出现腐烂或者腐坏的现象可以选择在食物当中添加山梨酸钾,可以防止食物变性的现象发生。而且山梨酸钾还用于很多的化妆品,在化妆品里也会看得到,它可以起到防腐的效果,不过它是属于一种有机酸类的防腐剂,适当的使用对人体是没有害处的。同时山梨酸钾还有降低细菌感染的作用,可以改善沙门氏菌、副溶血性弧菌等病菌,也可以用于折叠与蛋白质相互作用,也用于各种饮品和水果当中。
22、食用香精:一是为食品提供香味,如软饮料、冰淇淋、果冻、口香糖、糖果等;二是补充和改善食品的香味。
本发明的优点如下:具有美容养颜抗衰老、补水、锁水、清除自由基、改善睡眠、美白淡斑、修复软骨素等功效。
本发明的二氢槲皮素SOD胶原三肽饮在1个月、3个月周期中,正常每天1杯(350mm)的实验效果如下:
时间段 | 肤质改善 | 消炎排毒 | 美容养颜 |
1个月 | 有改善,一般效果 | 有改善,一般效果 | 有改善,一般效果 |
3个月 | 改善显著,效果佳 | 改善显著,效果佳 | 改善显著,效果佳 |
以上所述仅是本发明的较佳实施方式,故凡依本发明专利申请范围所述特征及原理所做的等效变化或修饰,均包括于本发明专利申请范围内。
Claims (4)
1.一种二氢槲皮素SOD胶原三肽饮配方,其特征在于:按质量百分比的组成成份如下:
纯化水60-80%、水蜜桃浓缩5-25%、木糖醇1-10%,透明质酸钠0.1-0.5%、胶原三肽1-6%、鲣鱼弹性蛋白肽0.5-3.5%、鳕鱼胶原蛋白肽0.5-3.5%、余甘子0.1-2.5%、雨生红球藻0.1-0.8%、氨基丁酸0.1-0.5%、燕窝0.1-0.5%、含Sod酵母粉0.05-0.15%、二氢槲皮素0.01-0.05%、维生素C0.01-0.05%、维生素E0.01-0.05%、烟酰胺0.005-0.015%、羧甲基纤维素钠0.005-0.015%、柠檬酸0.005-0.015%、L-苹果酸0.005-0.015%、三氯蔗糖0.001-0.009%、山梨酸钾0.001-0.009%、食用香精0.0005-0.005%。
2.根据权利要求1所述的一种二氢槲皮素SOD胶原三肽饮配方,其特征在于:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水71.389%、水蜜桃浓缩15%、木糖醇5%、透明质酸钠0.2%、胶原三肽3%、鲣鱼弹性蛋白肽2%、鳕鱼胶原蛋白肽2%、余甘子0.5%、雨生红球藻0.3%、氨基丁酸0.2%、燕窝0.2%、含Sod酵母粉0.1%、二氢槲皮素0.02%、维生素C0.02%、维生素E0.02%、烟酰胺0.01%、羧甲基纤维素钠0.01%、柠檬酸0.01%、L-苹果酸0.01%、三氯蔗糖0.005%、山梨酸钾0.004%、食用香精0.002%。
3.根据权利要求1所述的一种二氢槲皮素SOD胶原三肽饮配方,其特征在于:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水70.592%、水蜜桃浓缩13.5%、木糖醇4.5%、透明质酸钠0.15%、胶原三肽4%、鲣鱼弹性蛋白肽3%、鳕鱼胶原蛋白肽3%、余甘子0.4%、雨生红球藻0.2%、氨基丁酸0.25%、燕窝0.25%、含Sod酵母粉0.15%、二氢槲皮素0.025%、维生素C0.025%、维生素E0.025%、烟酰胺0.015%、羧甲基纤维素钠0.015%、柠檬酸0.015%、L-苹果酸0.015%、三氯蔗糖0.004%、山梨酸钾0.003%、食用香精0.001%。
4.根据权利要求1所述的一种二氢槲皮素SOD胶原三肽饮配方,其特征在于:二氢槲皮素SOD胶原三肽饮配方,按质量百分比的组成成份如下:
纯化水68.978%、水蜜桃浓缩12.5%、木糖醇4.%、透明质酸钠0.1%、胶原三肽5%、鲣鱼弹性蛋白肽4%、鳕鱼胶原蛋白肽4%、余甘子0.45%、雨生红球藻0.25%、氨基丁酸0.255%、燕窝0.255%、含Sod酵母粉0.155%、二氢槲皮素0.0255%、维生素C0.0255%、维生素E0.0255%、烟酰胺0.0155%、羧甲基纤维素钠0.0155%、柠檬酸0.0155%、L-苹果酸0.0155%、三氯蔗糖0.0045%、山梨酸钾0.0035%、食用香精0.0005%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210716964.0A CN114938835A (zh) | 2022-06-23 | 2022-06-23 | 一种二氢槲皮素sod胶原三肽饮配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210716964.0A CN114938835A (zh) | 2022-06-23 | 2022-06-23 | 一种二氢槲皮素sod胶原三肽饮配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114938835A true CN114938835A (zh) | 2022-08-26 |
Family
ID=82910333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210716964.0A Pending CN114938835A (zh) | 2022-06-23 | 2022-06-23 | 一种二氢槲皮素sod胶原三肽饮配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114938835A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116686927A (zh) * | 2023-06-09 | 2023-09-05 | 海南华研胶原科技股份有限公司 | 一种即食鱼胶原蛋白肽水蜜桃固体饮料 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730232A (zh) * | 2019-03-19 | 2019-05-10 | 达威控股有限公司 | 一种美容养颜饮品及其制备方法 |
CN113907224A (zh) * | 2021-10-15 | 2022-01-11 | 乐湃德(重庆)生物科技有限公司 | 一种透明质酸钠青春饮的组成配方 |
-
2022
- 2022-06-23 CN CN202210716964.0A patent/CN114938835A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730232A (zh) * | 2019-03-19 | 2019-05-10 | 达威控股有限公司 | 一种美容养颜饮品及其制备方法 |
CN113907224A (zh) * | 2021-10-15 | 2022-01-11 | 乐湃德(重庆)生物科技有限公司 | 一种透明质酸钠青春饮的组成配方 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116686927A (zh) * | 2023-06-09 | 2023-09-05 | 海南华研胶原科技股份有限公司 | 一种即食鱼胶原蛋白肽水蜜桃固体饮料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113180165A (zh) | 一种含透明质酸钠的养颜饮料及其制备方法 | |
CN111616364A (zh) | 一种红参阿胶饮品及其在保健饮品中的应用 | |
CN106266229B (zh) | 一种具有补血功效的酵素及其制备方法 | |
CN113907224A (zh) | 一种透明质酸钠青春饮的组成配方 | |
CN101703287A (zh) | 阿胶饮料及其制备方法 | |
CN102224891A (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
CN101012419A (zh) | 透明质酸在酒类中的应用及含透明质酸的啤酒 | |
CN103960729A (zh) | 低糖黑蒜花卉饮料及制备方法 | |
CN111387381A (zh) | 蓝靛果复合果汁饮料及其制备方法 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
CN110584101A (zh) | 爆珠燕窝、制备方法及饮品 | |
CN112602861A (zh) | 一种用于提高免疫力的担子菌复合饮品及其制备方法 | |
CN108740863A (zh) | 一种益气补血的组合物及其制备方法和应用 | |
CN104256782B (zh) | 一种葛根山杞饮料及其制备方法 | |
CN115736142A (zh) | 一种益生元西梅纤维果饮的配方及制备工艺 | |
CN109907191A (zh) | 一种刺梨酵素饮品及其制备方法 | |
CN105077435A (zh) | 一种酸甜口感的黑木耳姜汁饮料及其制备方法 | |
KR20210063657A (ko) | 헛개나무 추출물 및 백년초 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
CN114938835A (zh) | 一种二氢槲皮素sod胶原三肽饮配方 | |
CN116508917A (zh) | 一种透明质酸钠葫芦饮 | |
CN107668569A (zh) | 一种延缓衰老的海参蜂王浆及其生产方法 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
CN115119914A (zh) | 二青槲皮素鹿血海参肽饮配方 | |
CN105341591A (zh) | 一种浓缩型保健无花果汁 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |